Sermorelin/GHRP-2 18 mg/6 mg powder, Pharm D Solutions, Houston, Texas --- NDC 69699-1748-10
Pharm D Solutions
Lack of Assurance of Sterility
Prescription and over-the-counter medications
Pharm D Solutions
Lack of Assurance of Sterility
Pharm D Solutions
Lack of Assurance of Sterility
Aurobindo Pharma Limited (Unit I)
CGMP Deviation: Presence of NDEA (N-Nitrosodimethylamine), a carcinogen impurity, detected in the active ingredient.
Pharm D Solutions
Lack of Assurance of Sterility
Avella of Deer Valley, Inc. Store 38
Lack of assurance of sterility
Pharm D Solutions
Lack of Assurance of Sterility
CGMP Deviations: products manufactured by contract manufacturer under conditions that could result in possible microbial contamination.
Pharm D Solutions
Lack of Assurance of Sterility
Pharm D Solutions
Lack of Assurance of Sterility
Pharm D Solutions
Lack of Assurance of Sterility
Pharm D Solutions
Lack of Assurance of Sterility
Pharm D Solutions
Lack of Assurance of Sterility
CGMP Deviations: products manufactured by contract manufacturer under conditions that could result in possible microbial contamination.
Pharm D Solutions
Lack of Assurance of Sterility
Pharm D Solutions
Lack of Assurance of Sterility
Pharm D Solutions
Lack of Assurance of Sterility
Pharm D Solutions
Lack of Assurance of Sterility
Pharm D Solutions
Lack of Assurance of Sterility
Pharm D Solutions
Lack of Assurance of Sterility
Pharm D Solutions
Lack of Assurance of Sterility